The best approach for protecting everyone’s health will require us to provide different vaccines to different people according to need and availability.
Academic rigor, journalistic flair
Articles on COVID vaccines
Displaying 1 - 20 of 23 articles
Despite the latest tweaks to border testing rules, the risk of imported infection remains very high. NZ's wider response needs upgrading —including reducing the large numbers of infected returnees.
With reports emerging of vaccine wastage across the world, medical supply chain experts explain why that's to be expected.
A waiver on some intellectual property rules at the WTO for COVID-19 vaccines would ensure more equitable access, but wouldn't solve all the problems facing developing countries.
COVID-19 vaccines could substantially reduce hospital admissions, but will be slower at freeing up space in intensive care.
A medical professor explains the reasoning behind the delay in the UK and what impact this might have on the vaccine's effectiveness.
Our research can help understand the role schools play in transmission.
Researchers say around 70% of the US needs to get the coronavirus vaccine to stop the pandemic. But questions around the vaccines and regional differences add some uncertainty to that estimate.
Black people are skeptical about the new vaccines for many reasons. If public health leaders told the full story, maybe there'd be a higher chance that Black people would want to take the vaccine.
The federal agency in charge of enforcing discrimination laws in the workplace said 'yes,' but there are some important exceptions and limitations.
Experts from across The Conversation assess the work that's helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
Here's what we still need to find out before we can know when we'll be able to return to our pre-coronavirus ways.
So, if you have ever tested positive, there is a chance you could contract the virus again. And you could infect other people. You should still take the necessary precautions.
COVID-19 vaccines have very specific storage requirements that make shipping a difficult task. Two ideas – fulfillment centers and cross-docking – could help overcome some distribution challenges.
Health systems around the US are on the cusp of receiving COVID-19 vaccines. At the end of this months-long effort are the nitty-gritty details of how health care providers are giving people the vaccine.
New research shows why the N protein might be a good target.
At least three Chinese vaccines have been approved for emergency use, while phase 3 clinical trials are ongoing.
Implausible theories give believers control over a puzzling and threatening world.
What if I've had COVID? Should I still get the vaccine?
Unprecedented efforts are driving the global push for a safe and effective vaccine. If and when we have one (or more), here's how it's likely to be rolled out in Australia.
Top contributors
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Associate professor, UNSW
-
Professor in Infectious Diseases Epidemiology, Monash University
-
Professor and Distinguished Research Chair, Globalization and Health Equity, L’Université d’Ottawa/University of Ottawa
-
Professor of Public Health, University of Otago
-
Professor of Public Health, University of Otago
-
Deputy Vice-Chancellor: Research and Internationalisation, University of Johannesburg
-
Assistant Professor of Law, Saint Louis University
-
Associate Professor, University of Melbourne, Murdoch Children's Research Institute
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Senior Lecturer in Marketing, University of Huddersfield
-
Paediatrician, Infectious Diseases Physician and Clinical Microbiologist, University of Western Australia
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford
-
Professor of Inflammatory Disease, University of Manchester
